Chest ACCP Member Benefits
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     

Guest Access | Sign In via User Name/Password
This Article
Right arrow Full Text Free
Right arrow Full Text (PDF) Free
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Article Archive
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (14)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Gilljam, M.
Right arrow Articles by Tullis, D. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gilljam, M.
Right arrow Articles by Tullis, D. E.
(Chest. 2004;126:1215-1224.)
© 2004 American College of Chest Physicians

Clinical Manifestations of Cystic Fibrosis Among Patients With Diagnosis in Adulthood*

Marita Gilljam, MD; Lynda Ellis, RN; Mary Corey, PhD; Julian Zielenski, PhD; Peter Durie, MD and D. Elizabeth Tullis, MD, FCCP

* From the Department of Respiratory Medicine and Allergology, Sahlgrenska University Hospital (Dr. Gilljam), Goteborg University, Goteborg, Sweden; Department of Pediatrics (Ms. Ellis and Dr. Durie) and Research Institute (Drs. Zielenski and Durie), Program of Population Health Science (Dr. Corey), Hospital for Sick Children, Adult CF Program, St Michael’s Hospital, Departments of Medicine and Pediatrics (Dr. Tullis), University of Toronto, Toronto, ON, Canada.

Correspondence to: D. Elizabeth Tullis, MD, FCCP, Room 6–045, Bond Wing, St Michael’s Hospital, 30 Bond St, Toronto, ON, M5B 1W8, Canada; e-mail: tullise{at}smh.toronto.on.ca

Objective: To define the clinical characteristics and diagnostic parameters of patients with cystic fibrosis (CF) diagnosed in adulthood.

Design: Retrospective cohort study.

Setting: Tertiary care center.

Patients and methods: All patients with a diagnosis of CF made at the Toronto CF Clinics between 1960 and June 2001. Data were collected prospectively and analyzed retrospectively.

Results: There were 73 of 1,051 patients (7%) with CF diagnosed in adulthood. Over time, an increasing number and proportion of patients received a diagnosis in adulthood: 27 patients (3%) before 1990, compared to 46 patients (18%) after 1990 (p < 0.001). The mean sweat chloride level was lower for those with CF diagnosed as adults, compared to those with a diagnosis as children (75 ± 26 mmol/L and 100 ± 19 mmol/L, respectively; p < 0.001) [mean ± SD], and adults were more likely to have pancreatic sufficiency (PS) than children (73% vs 13%, respectively; p < 0.0001). In 46 adults who received a diagnosis since 1990, the reason for the initial sweat test was pancreatitis (2 patients, 4%), pulmonary symptoms (18 patients, 39%), pulmonary and GI symptoms (10 patients, 22%), infertility (12 patients, 26%), and genetic screening (4 patients, 9%). Other manifestations were biliary cirrhosis (one patient) and diabetes mellitus (four patients, 9%). The diagnosis could be confirmed by sweat test alone in 30 of 46 patients (65%), by mutation analysis alone in 15 patients (33%), and by a combination in 31 patients (67%). Nasal potential difference (PD) measurements alone confirmed the diagnosis in the remaining 15 patients (33%).

Conclusion: Patients with CF presenting in adulthood often have PS, inconclusive sweat test results, and a high prevalence of mutations that are not commonly seen in CF diagnosed in childhood. Although most patients have lung disease of variable degrees, single-organ manifestations such as congenital bilateral absence of the vas deferens and pancreatitis are seen. Repeated sweat tests and extensive mutation analysis are often required. Nasal PD may aid the diagnosis, but has not been standardized for clinical diagnosis.

Key Words: adult • cystic fibrosis • cystic fibrosis transmembrane conductance regulator • diagnosis • genotype • ion transport




This article has been cited by other articles:


Home page
Eur Respir JHome page
I. Dugueperoux and M. De Braekeleer
The CFTR 3849+10kbC->T and 2789+5G->A alleles are associated with a mild CF phenotype
Eur. Respir. J., March 1, 2005; 25(3): 468 - 473.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2004 by the American College of Chest Physicians.